Familial uterine leiomyoma-associated germline oncogenic mutant VEGFR1 is sensitive to mTOR inhibitor.

Dai, Yuxin; Zhang, Xinyu; Lv, Jiarui; Feng, Fengzhi; Wan, Xirun; Huang, Fuqiang; Zhang, Hongbing; Zhu, Lan

Dai, Yuxin; Zhang, Xinyu; Lv, Jiarui; Feng, Fengzhi; Wan, Xirun; Huang, Fuqiang; Zhang, Hongbing; Zhu, Lan.

Afiliación

Dai Y; Department of Obstetrics and Gynecology, State Key Laboratory of Complex, Severe and Rare Diseases, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730,
Zhang X; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
Lv J; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China; Department of Physiology, School of Life Science, China Medical
Feng F; Department of Obstetrics and Gynecology, State Key Laboratory of Complex, Severe and Rare Diseases, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730,
Wan X; Department of Obstetrics and Gynecology, State Key Laboratory of Complex, Severe and Rare Diseases, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730,
Huang F; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
Zhang H; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China. Electronic address: hbzhang@ibms.pumc.edu.cn.
Zhu L; Department of Obstetrics and Gynecology, State Key Laboratory of Complex, Severe and Rare Diseases, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730,

Sci Bull (Beijing) ; 67(6): 585-587, 2022 03 30.

Article en En | MEDLINE | ID: mdl-36546119

Asunto(s)

Leiomioma; Neoplasias Uterinas; Humanos; Femenino; Leiomioma/tratamiento farmacológico; Neoplasias Uterinas/tratamiento farmacológico; Inhibidores mTOR; Serina-Treonina Quinasas TOR/genética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Leiomioma Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Sci Bull (Beijing) Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google